RLS-0071, A Novel Dual-targeting Anti-inflammatory Agent, Demonstrates Proof of Mechanism in a Phase 1b Inhaled LPS Study Significantly Reducing Lung Neutrophils-MedSci.cn

RLS-0071, A Novel Dual-targeting Anti-inflammatory Agent, Demonstrates Proof of Mechanism in a Phase 1b Inhaled LPS Study Significantly Reducing Lung Neutrophils

Hohlfeld, JM; Holz, O; Müller, M; Carstensen, S; Dell, L; Goss, J; Hair, P; Badorrek, P; Cunnion, K; Thienel, U

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023; 207 ():

科室
- - 订阅+
  - 更多科室
工具
服务